by Infertility Drugs: A Closer Look at the Different Treatment Options Available
Infertility, or the inability to conceive a child after a year of unprotected sex, affects approximately 15% of reproductive-aged couples worldwide. While lifestyle changes and medical treatments can help identify and treat underlying causes of infertility in some cases, reproductive technologies such as infertility drugs are often necessary to help induce ovulation, support embryo development, and increase the chances of achieving a successful pregnancy. This article will examine some of the most common types of infertility drugs used as part of assisted reproductive technology treatments.
Ovulation Induction Medications
One of the primary reasons couples struggle with infertility is due to ovulatory disorders that prevent the release of a mature egg each month. Drugs used for ovulation induction help stimulate and support the development of follicles within the ovaries. Some common ovulation induction medications include:
– Clomiphene citrate (Clomid, Serophene): An oral medication, clomiphene citrate is usually the first line treatment for anovulation. It works by blocking estrogen receptors in the brain to stimulate the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn trigger follicle development and ovulation.
– Letrozole (Femara): An aromatase inhibitor that works similarly to clomiphene by elevating FSH levels through a decrease in estrogen production. It is often prescribed for patients who do not respond well to clomiphene therapy.
– Gonadotropins: These injections contain FSH, LH, or both hormones to actively stimulate follicle growth. Common gonadotropin medications include Menopur, Bravelle, Follistim and Gonal-f. They provide a stronger stimulation effect than oral medications but also carry greater risk of ovarian hyperstimulation syndrome (OHSS).
Luteal Phase Support
Even if ovulation is successfully induced, fertility drugs are sometimes needed in the luteal phase, or second half, of the menstrual cycle to support implantation and the early development of an embryo. Common luteal phase support medications include:
– Progesterone supplements: Given as vaginal inserts, injections or oral capsules after ovulation, progesterone helps thicken the uterine lining and maintain early pregnancy until the placenta is adequately developed.
– HCG trigger shot: A human chorionic gonadotropin (hCG) injection is administered to trigger ovulation after follicles have matured during an infertility treatment cycle. It also helps prepare the corpus luteum to secrete progesterone through the early stages of pregnancy.
Intracytoplasmic Sperm Injection (ICSI) Medications
For couples undergoing intracytoplasmic sperm injection (ICSI) as part of in vitro fertilization (IVF) treatment, additional infertility medications may be prescribed for ovarian stimulation and to help support embryonic development. Multiple paragraphs article continued below.
Embryo Culture Medications
After fertilization via ICSI, embryo culture medications are used to maintain an optimal environment for pre-implantation embryo growth in the laboratory. One of the most common types is corticosteroids like prednisolone, which help reduce early embryo losses from immune system attacks. Amino acids like l-carnitine are also sometimes included in embryo culture media to promote metabolism and viability. These specialized solutions aim to mimic the natural conditions in the fallopian tubes and uterus as closely as possible.
Preimplantation Genetic Testing
As preimplantation genetic testing (PGT) for screening or diagnosing genetic abnormalities in embryos prior to transfer has become more widespread, additional medications may be used as part of the process. For example, embryos may be cultured for an additional 24-48 hours to allow cells to naturally fall off for biopsy and subsequent genetic analysis. Morphokinetic monitoring drugs like adenosine triphosphate (ATP) gauges are sometimes employed as non-invasive markers of embryo health and development during that extended culture period.
Embryo Transfer Medications
To prepare the uterine lining and support optimal embryo attachment, a short course of estradiol, progesterone and sometimes testosterone is typically administered leading up to an embryo transfer during an IVF cycle. A single hCG trigger injection is also given 34-36 hours before the procedure to induce final maturation of the endometrium. In cases of frozen embryo transfers, a similar hormone regimen is followed to synchronize the cycle with a frozen embryos’ stage of development.
Post-Transfer Luteal Phase Support
Robust progesterone supplementation from ovulation through early pregnancy is considered essential to maintaining uterine conditions conducive to implantation and continuing embryonic development if transfer is successful. Progesterone is usually administered through either vaginal gel, capsule, suppository or intramuscular injection for 10-16 days post embryo transfer. Sometimes an additional estradiol medication is also prescribed to balance estradiol levels and fully support endometrial development. This critical post-transfer period is monitored with frequent pregnancy blood tests.
Infertility drug advancements now allow many previously infertile couples to achieve successful pregnancies and deliver healthy babies. Utilizing the optimal medication protocols tailored specifically for individualized medical histories and diagnoses provides the best chances for treatment success. With continued research into new treatments and technologies, reproductive endocrinologists hope to further expand fertility preservation and family building options to assist even more people struggling with infertility worldwide.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
